SHH Equity Snapshot
688180 Weekly Equity Report
Shanghai Junshi Biosciences Co., Ltd.
What the company does
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China. The company's product pipelines include Tifcemalimab, an anti- B and T lymphocyte attenuator mAB which is in phase III clinical trial to treat lung cancer and lymphocyte; Roconkibart, an anti-interleukin-17A monoclonal antibody which is in phase III clinical trial to treat psoriatic and spondylitis; JS001sc, a subcutaneous injection which is in phase III clinical trial for the treatment of tumors; JS105, an oral small molecule inhibitor targeting PI3K-a which is in phase III clinical trial …
What the weekly tape is saying
688180 closed the latest completed week at 30.69 CNY. The 4-week return is -20.4% and the 12-week return is -5.3%. Trend Signal is inactive, Market Dynamics is -0.22. Setup signature: Risk-first tape with a 16/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 36.03 CNY
- Vs Trend Line
- -14.8%
- Fair Value
- 34.30 CNY
- Vs Fair Value
- -10.5%
- 52W High
- 51.40 CNY
- 52W Low
- 28.10 CNY
- Drawdown
- -40.3%
- Range Position
- 11.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- CN Healthcare
- Sector Rank
- 79 of 486
- Sector Percentile
- 83.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 95 of 100
- Avg 1W
- -0.2%
- Avg 4W
- -7.7%
- Trend Breadth
- 15.0%
- Positive MD
- 24.0%
CN Biotechnology
- Tracked Peers
- 100
- 4W Rank
- 84 of 100
- Avg 1W
- -1.1%
- Avg 4W
- -13.2%
- Trend Breadth
- 13.0%
- Positive RS
- 10.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.22
- 4W MD Change
- -125.0%
- Relative Strength
- -21.97
- 4W RS Change
- -317.6%
- Expectation
- Undecided
- Probability
- 46.00%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 65.1M
- 13W Average
- 87.7M
- 52W Average
- 70.9M
- Vs 13W
- 0.7x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.6%
- 52W Volatility
- 7.0%
- Upside Weeks
- 22
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 6.4% / -4.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SHH
- Country
- CN
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- CNY
- Market Cap
- 33.0B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 30.69 CNY | 1.9% | 36.03 CNY | 34.30 CNY | -0.22 | -21.97 | 65.1M | Off |
| 5 Jun 2026 | 30.12 CNY | -12.0% | 36.27 CNY | 34.41 CNY | 0.17 | -23.68 | 88.6M | Off |
| 29 May 2026 | 34.24 CNY | -7.8% | 36.61 CNY | 34.53 CNY | 0.45 | -14.48 | 74.7M | On |
| 22 May 2026 | 37.13 CNY | -3.7% | 36.73 CNY | 34.64 CNY | 0.71 | -8.33 | 79.0M | On |
| 15 May 2026 | 38.55 CNY | -2.1% | 36.78 CNY | 34.73 CNY | 0.87 | -5.26 | 92.6M | On |
| 8 May 2026 | 39.36 CNY | -2.5% | 36.82 CNY | 34.82 CNY | 1.06 | -4.18 | 43.7M | Off |
| 1 May 2026 | 40.38 CNY | 1.5% | 36.89 CNY | 34.91 CNY | 1.14 | -0.04 | 78.0M | Off |
| 24 Apr 2026 | 39.80 CNY | -11.6% | 36.91 CNY | 35.00 CNY | 1.18 | -0.52 | 113.6M | Off |
| 17 Apr 2026 | 45.04 CNY | 18.3% | 37.05 CNY | 35.08 CNY | 0.84 | 13.59 | 149.6M | Off |
| 10 Apr 2026 | 38.08 CNY | -1.8% | 37.17 CNY | 35.10 CNY | 0.32 | -1.99 | 74.5M | Off |
| 3 Apr 2026 | 38.79 CNY | 15.1% | 37.50 CNY | 35.17 CNY | -0.12 | 2.59 | 127.8M | Off |
| 27 Mar 2026 | 33.70 CNY | 4.0% | 37.71 CNY | 35.24 CNY | -0.59 | -11.46 | 70.3M | Off |
| 20 Mar 2026 | 32.40 CNY | 4.5% | 38.12 CNY | 35.36 CNY | -0.67 | -15.83 | 83.0M | Off |
| 13 Mar 2026 | 31.00 CNY | -0.7% | 38.44 CNY | 35.49 CNY | -0.68 | -22.25 | 67.7M | Off |